Ultrahuman Acquires viO HealthTech to Add OvuSense Ovulation Tech
August 15, 2025
Ultrahuman has acquired viO HealthTech and launched Cycle & Ovulation Pro for its Ultrahuman Ring AIR, integrating viO's clinically validated OvuSense ovulation-tracking algorithm into the ring using finger-based temperature sensing. viO's technology — developed over 15 years with FDA 510(k) clearance and CE Class IIa certifications — will be offered as a paid subscription across the US, UK, EU, Canada and Australia. The deal brings clinical-grade women's health capability to Ultrahuman's consumer wearable platform to improve cycle and ovulation insights.
- Buyers
- Ultrahuman
- Targets
- viO HealthTech
- Industry
- Medical Devices
- Location
- Connecticut, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Oura Acquires Metabolic Health Startup Veri
September 11, 2024
Healthcare Services
Wearable-health company Oura has acquired Helsinki-based metabolic health startup Veri and will fold Veri’s platform and team into Oura’s health suite. Financial terms were not disclosed; Oura said the Veri brand will be retired by the end of 2024 and it intends to absorb as much of Veri’s staff as makes sense.
-
Labcorp Acquires Ovia Health
August 12, 2021
Healthcare Services
Labcorp acquired Ovia Health, a digital women's health platform that supports family planning, pregnancy and parenting, to expand its women's health capabilities and digital offerings. The acquisition builds on a prior strategic investment from Labcorp's Venture Fund and aims to combine Labcorp's diagnostics and genetics expertise with Ovia's digital platform to improve patient experience and outcomes; terms were not disclosed.
-
Olympus to Acquire Odin Vision
December 20, 2022
Medical Devices
Olympus Corporation has signed a definitive agreement to acquire London-based Odin Vision, a cloud-AI endoscopy company, for up to GBP 66 million in upfront and milestone payments. The purchase is part of Olympus' broader digital strategy to integrate AI-driven detection, diagnostics, and cloud-enabled workflow solutions into its Digital Endosuite to improve clinical decision-making and patient outcomes.
-
EcoVadis Acquires Ulula
September 4, 2024
Data & Analytics
EcoVadis has acquired Ulula, a human-rights technology and analytics company, to integrate Ulula's worker engagement platform and analytics into EcoVadis' sustainability intelligence offerings. The acquisition strengthens EcoVadis' ability to provide on-the-ground, verifiable labor and human-rights data to customers and supports compliance with evolving global supply-chain regulations.
-
Granata Bio Acquires Oviva Therapeutics
April 29, 2025
Biotechnology
Granata Bio has acquired Oviva Therapeutics, a women's health biotech developing OVI-586, a first-in-class therapeutic aimed at extending ovarian function and improving reproductive outcomes. The acquisition expands Granata's fertility and women's health pipeline and will advance OVI-586 toward further development for applications including menopause, contraception, and in vitro fertilization (IVF).
-
Vizgen Acquires Ultivue (Merger to Form Combined Spatial Biology Company)
October 9, 2024
Biotechnology
Vizgen and Ultivue have merged to create a single spatial biology company that combines Vizgen’s MERFISH single-cell spatial genomics platform with Ultivue’s InSituPlex assays and STARVUE proteomic/AI capabilities. Rob Carson (former CEO of Ultivue) will serve as President and CEO of the combined Vizgen, and the transaction was completed alongside Vizgen’s Series D financing backed by investors including ARCH Venture Partners, Northpond Ventures and Tao Capital Partners.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.